, volume 30 , issue 1 , pages 27-38

Current status of GPR40/FFAR1 modulators in medicinal chemistry (2016–2019): a patent review

Li Zheng ^{1, 2}

Zongtao Zhou ¹

Luyong Zhang ^{1, 2, 3, 4}

Hide authors affiliations Show authors affiliations: 4 affiliations

School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, PR China |

Key Laboratory of New Drug Discovery and Evaluation of ordinary universities of Guangdong province, Guangdong Pharmaceutical University, Guangzhou, PR China |

Guangzhou Key Laboratory of Construction and Application of New Drug Screening Model Systems, Guangdong Pharmaceutical University, Guangzhou, PR China |

⁴

Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing, PR China |

Publication type: Journal Article

Publication date: 2019-12-02

Taylor & Francis

Expert Opinion on Therapeutic Patents

scimago Q1

wos Q1

SJR: 1.200

CiteScore: 10.3

Impact factor: 4.6

ISSN: 13543776, 17447674

DOI: 10.1080/13543776.2020.1698546

Copy DOI

PubMed ID: 31771391

Drug Discovery

General Medicine

Pharmacology

Found

2 citations

Luzina Olga

DSc in Chemistry

105 publications, 1 288 citations, 22 reviews

h-index: 21

N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry of the Siberian Branch of the Russian Academy of Sciences

Research interests

Chemistry of natural compounds

Medicinal Chemistry

Organic Chemistry

Top-30

Journals

	1 2 3
European Journal of Medicinal Chemistry	European Journal of Medicinal Chemistry, 3, 5.77% European Journal of Medicinal Chemistry 3 publications, 5.77%
Biomedicine and Pharmacotherapy	Biomedicine and Pharmacotherapy, 3, 5.77% Biomedicine and Pharmacotherapy 3 publications, 5.77%
International Journal of Molecular Sciences	International Journal of Molecular Sciences, 2, 3.85% International Journal of Molecular Sciences 2 publications, 3.85%
ChemistrySelect	ChemistrySelect, 2, 3.85% ChemistrySelect 2 publications, 3.85%
Journal of Medicinal Chemistry	Journal of Medicinal Chemistry, 2, 3.85% Journal of Medicinal Chemistry 2 publications, 3.85%
Molecular Pharmacology	Molecular Pharmacology, 1, 1.92% Molecular Pharmacology 1 publication, 1.92%
Mini-Reviews in Medicinal Chemistry	Mini-Reviews in Medicinal Chemistry, 1, 1.92% Mini-Reviews in Medicinal Chemistry 1 publication, 1.92%
Frontiers in Bioengineering and Biotechnology	Frontiers in Bioengineering and Biotechnology, 1, 1.92% Frontiers in Bioengineering and Biotechnology 1 publication, 1.92%
Frontiers in Pharmacology	Frontiers in Pharmacology, 1, 1.92% Frontiers in Pharmacology 1 publication, 1.92%
Inflammopharmacology	Inflammopharmacology, 1, 1.92% Inflammopharmacology 1 publication, 1.92%
Journal of Molecular Modeling	Journal of Molecular Modeling, 1, 1.92% Journal of Molecular Modeling 1 publication, 1.92%
Biochimica et Biophysica Acta - Molecular Cell Research	Biochimica et Biophysica Acta - Molecular Cell Research, 1, 1.92% Biochimica et Biophysica Acta - Molecular Cell Research 1 publication, 1.92%
Obesity Medicine	Obesity Medicine, 1, 1.92% Obesity Medicine 1 publication, 1.92%
Mendeleev Communications	Mendeleev Communications, 1, 1.92% Mendeleev Communications 1 publication, 1.92%
PLoS ONE	PLoS ONE, 1, 1.92% PLoS ONE 1 publication, 1.92%
Bioorganic Chemistry	Bioorganic Chemistry, 1, 1.92% Bioorganic Chemistry 1 publication, 1.92%
Drug Discovery Today	Drug Discovery Today, 1, 1.92% Drug Discovery Today 1 publication, 1.92%
Bioorganic and Medicinal Chemistry Letters	Bioorganic and Medicinal Chemistry Letters, 1, 1.92% Bioorganic and Medicinal Chemistry Letters 1 publication, 1.92%
Archiv der Pharmazie	Archiv der Pharmazie, 1, 1.92% Archiv der Pharmazie 1 publication, 1.92%
Journal of Neurochemistry	Journal of Neurochemistry, 1, 1.92% Journal of Neurochemistry 1 publication, 1.92%
FEBS Journal	FEBS Journal, 1, 1.92% FEBS Journal 1 publication, 1.92%
ACS Medicinal Chemistry Letters	ACS Medicinal Chemistry Letters, 1, 1.92% ACS Medicinal Chemistry Letters 1 publication, 1.92%
Xenobiotica	Xenobiotica, 1, 1.92% Xenobiotica 1 publication, 1.92%
Expert Opinion on Drug Discovery	Expert Opinion on Drug Discovery, 1, 1.92% Expert Opinion on Drug Discovery 1 publication, 1.92%
Journal of Pharmacy and Pharmacology	Journal of Pharmacy and Pharmacology, 1, 1.92% Journal of Pharmacy and Pharmacology 1 publication, 1.92%
Biomolecules and Therapeutics	Biomolecules and Therapeutics, 1, 1.92% Biomolecules and Therapeutics 1 publication, 1.92%
Stem Cells International	Stem Cells International, 1, 1.92% Stem Cells International 1 publication, 1.92%
American Journal of Physiology - Endocrinology and Metabolism	American Journal of Physiology - Endocrinology and Metabolism, 1, 1.92% American Journal of Physiology - Endocrinology and Metabolism 1 publication, 1.92%
Annual Review of Pharmacology and Toxicology	Annual Review of Pharmacology and Toxicology, 1, 1.92% Annual Review of Pharmacology and Toxicology 1 publication, 1.92%
	1 2 3

Publishers

	2 4 6 8 10 12 14 16
Elsevier	Elsevier, 16, 30.77% Elsevier 16 publications, 30.77%
Wiley	Wiley, 7, 13.46% Wiley 7 publications, 13.46%
MDPI	MDPI, 5, 9.62% MDPI 5 publications, 9.62%
Bentham Science Publishers Ltd.	Bentham Science Publishers Ltd., 3, 5.77% Bentham Science Publishers Ltd. 3 publications, 5.77%
American Chemical Society (ACS)	American Chemical Society (ACS), 3, 5.77% American Chemical Society (ACS) 3 publications, 5.77%
Taylor & Francis	Taylor & Francis, 3, 5.77% Taylor & Francis 3 publications, 5.77%
Frontiers Media S.A.	Frontiers Media S.A., 2, 3.85% Frontiers Media S.A. 2 publications, 3.85%
Springer Nature	Springer Nature, 2, 3.85% Springer Nature 2 publications, 3.85%
American Society for Pharmacology and Experimental Therapeutics	American Society for Pharmacology and Experimental Therapeutics, 1, 1.92% American Society for Pharmacology and Experimental Therapeutics 1 publication, 1.92%
OOO Zhurnal "Mendeleevskie Soobshcheniya"	OOO Zhurnal "Mendeleevskie Soobshcheniya", 1, 1.92% OOO Zhurnal "Mendeleevskie Soobshcheniya" 1 publication, 1.92%
Public Library of Science (PLoS)	Public Library of Science (PLoS), 1, 1.92% Public Library of Science (PLoS) 1 publication, 1.92%
Korean Society of Applied Pharmacology	Korean Society of Applied Pharmacology, 1, 1.92% Korean Society of Applied Pharmacology 1 publication, 1.92%
Hindawi Limited	Hindawi Limited, 1, 1.92% Hindawi Limited 1 publication, 1.92%
American Physiological Society	American Physiological Society, 1, 1.92% American Physiological Society 1 publication, 1.92%
Annual Reviews	Annual Reviews, 1, 1.92% Annual Reviews 1 publication, 1.92%
Far Eastern Scientific Center Of Physiology and Pathology of Respiration	Far Eastern Scientific Center Of Physiology and Pathology of Respiration, 1, 1.92% Far Eastern Scientific Center Of Physiology and Pathology of Respiration 1 publication, 1.92%
Cold Spring Harbor Laboratory	Cold Spring Harbor Laboratory, 1, 1.92% Cold Spring Harbor Laboratory 1 publication, 1.92%
American Association for the Advancement of Science (AAAS)	American Association for the Advancement of Science (AAAS), 1, 1.92% American Association for the Advancement of Science (AAAS) 1 publication, 1.92%
Proceedings of the National Academy of Sciences (PNAS)	Proceedings of the National Academy of Sciences (PNAS), 1, 1.92% Proceedings of the National Academy of Sciences (PNAS) 1 publication, 1.92%
	2 4 6 8 10 12 14 16

We do not take into account publications without a DOI.
Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.

Metrics

Cite this

GOST |

Cite this

GOST Copy

Zheng L. et al. Current status of GPR40/FFAR1 modulators in medicinal chemistry (2016–2019): a patent review // Expert Opinion on Therapeutic Patents. 2019. Vol. 30. No. 1. pp. 27-38.

GOST all authors (up to 50) Copy

Zheng L., Zhou Z., Zhang L. Current status of GPR40/FFAR1 modulators in medicinal chemistry (2016–2019): a patent review // Expert Opinion on Therapeutic Patents. 2019. Vol. 30. No. 1. pp. 27-38.

RIS |

Cite this

RIS Copy

TY - JOUR

DO - 10.1080/13543776.2020.1698546

UR - https://doi.org/10.1080/13543776.2020.1698546

TI - Current status of GPR40/FFAR1 modulators in medicinal chemistry (2016–2019): a patent review

T2 - Expert Opinion on Therapeutic Patents

AU - Zheng, Li

AU - Zhou, Zongtao

AU - Zhang, Luyong

PY - 2019

DA - 2019/12/02

PB - Taylor & Francis

SP - 27-38

IS - 1

VL - 30

PMID - 31771391

SN - 1354-3776

SN - 1744-7674

ER -

BibTex |

Cite this

BibTex (up to 50 authors) Copy

@article{2019_Zheng,

author = {Li Zheng and Zongtao Zhou and Luyong Zhang},

title = {Current status of GPR40/FFAR1 modulators in medicinal chemistry (2016–2019): a patent review},

journal = {Expert Opinion on Therapeutic Patents},

year = {2019},

volume = {30},

publisher = {Taylor & Francis},

month = {dec},

url = {https://doi.org/10.1080/13543776.2020.1698546},

number = {1},

pages = {27--38},

doi = {10.1080/13543776.2020.1698546}

}

MLA

Cite this

MLA Copy

Zheng, Li, et al. “Current status of GPR40/FFAR1 modulators in medicinal chemistry (2016–2019): a patent review.” Expert Opinion on Therapeutic Patents, vol. 30, no. 1, Dec. 2019, pp. 27-38. https://doi.org/10.1080/13543776.2020.1698546.

Publisher

Taylor & Francis

Journal

Expert Opinion on Therapeutic Patents

scimago Q1

wos Q1

SJR

1.200

CiteScore

10.3

Impact factor

4.6

ISSN

13543776 (Print)

17447674 (Electronic)